ArticleArXiv2025
Hierarchical Molecular Language Models (HMLMs).
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Artificial intelligence (AI) is reshaping computational and network biology by enabling new approaches to decode cellular communication networks. We introduce Hierarchical Molecular Language Models (HMLMs), a novel framework that models cellular signaling as a specialized molecular language, where signaling molecules function as tokens, protein interactions define syntax, and functional consequences constitute semantics. HMLMs employ a transformer-based architecture adapted to accommodate graph-structured signaling networks through information transducers, mathematical entities that capture how molecules receive, process, and transmit signals. The architecture integrates multi-modal data sources across molecular, pathway, and cellular scales through hierarchical attention mechanisms and scale-bridging operators that enable information flow across biological hierarchies. Applied to a complex network of cardiac fibroblast signaling, HMLMs outperformed traditional approaches in temporal dynamics prediction, particularly under sparse sampling conditions. Attention-based analysis revealed biologically meaningful crosstalk patterns, including previously uncharacterized interactions between signaling pathways. By bridging molecular mechanisms with cellular phenotypes through AI-driven molecular language representation, HMLMs establish a foundation for biology-oriented large language models (LLMs) that could be pre-trained on comprehensive pathway datasets and applied across diverse signaling systems and tissues, advancing precision medicine and therapeutic discovery.
Indexed as
Identifiers
41415605PMC12709492What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.